Stromatt Scott C 4
4 · Aptevo Therapeutics Inc. · Filed Mar 5, 2018
Insider Transaction Report
Form 4
Stromatt Scott C
Chief Medical Officer and SVP
Transactions
- Exercise/Conversion
Common Stock
2018-03-01+16,269→ 190,845 total - Exercise/Conversion
Restricted Stock Unit
2018-03-01−16,269→ 30,161 total→ Common Stock (16,269 underlying)
Footnotes (2)
- [F1]Each RSU converts into the Issuer's common stock on a one-for-one basis.
- [F2]The RSUs were originally issued by Emergent BioSolutions, Inc. ("Emergent") on March 1, 2016. As a result of the spin-off of the Issuer from Emergent effective on August 1, 2016 (the "Spin-off"), each RSU was adjusted and assumed by the Issuer. The RSUs vest in three equal annual installments on the anniversary of the grant date.